HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Donna Karan first quarter beauty sales up 39.5%; IPO to raise $213. mil.

This article was originally published in The Rose Sheet

Executive Summary

DONNA KARAN FIRST QUARTER BEAUTY SALES JUMP 39.5%, or $1.3 mil., from the year-ago period, primarily due to "the expanded product offering in 1996 compared to 1995," according to an amended initial public offering prospectus filed with the Securities and Exchange Commission May 28. The fashion company's beauty portfolio comprises the Donna Karan New York collection of women's fragrances and bath and body products, Bath & Body Mist women's scent, and two men's scents -- DK Men (with auxiliary products) and Unleaded, a lighter version of DK Men.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002893

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel